Magnolia Neurosciences

Magnolia Neurosciences

Magnolia Neurosciences

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Raised
$62M
Follow us
Alexa global traffic share
Latest funding
$31,000,000
Venture capital (Series A) - 2018
Partnership Fund for New York City ARCH Venture Partners L.P. +9
$31,000,000
Venture capital (Series A) - 2018
MD Anderson Cancer Center Accelerator Life Science Partners
Team Size
1–10
Employees
$31,000,000 Venture capital (Series A)
FinSMEs

Magnolia Neurosciences Raises $31M in Series A Funding

Funding Science